PRSS8 and gastric cancer: Recently, Sun and Liu et al. reported that HOXA11-AS functions as a scaffold that could bind several RNA-binding proteins (WDR5, PRC2, LSD1, and DNMT1) and inhibit PRSS8 and KLF2 at the transcriptional level, thereby further stimulating β‐catenin protein and promoting GC progression32,33.